Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 32944-32945 [E9-16223]
Download as PDF
<![CDATA[
32944
Federal Register / Vol. 74, No. 130 / Thursday, July 9, 2009 / Notices
Reviews was established to aid the Advisory
Board in carrying out its duty to advise the
Secretary, HHS, on dose reconstruction. It is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Office of Compensation Analysis
and Support (OCAS) and its dose
reconstruction contractor.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes:
preparation of status report to the Secretary
on procedures review; a discussion of SC&A
Findings and NIOSH Responses on OCAS–
IG–004 (‘‘The Use of Data from Other
Facilities in the Completion of Dose
Reconstructions under EEOICPA’’)
concerning the use of ‘‘surrogate data’’;
discussion of the following ORAU
procedures: OTIB–0035 (‘‘Internal Dosimetry
Co-worker Data for K–25’’), OTIB–0052
(‘‘Parameters to Consider when Processing
claims for Construction Trades Workers’’),
OTIB–0047 (External Radiation monitoring at
Y–12 During the 1948–1949 Period’’), and
OTIB–0049 (‘‘Estimating Doses for Plutonium
Strongly Retained in the Lung’’); and, a
continuation of the comment-resolution
process for other dose reconstruction
procedures under review by the
Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public, but
without a public comment period. In the
event an individual wishes to provide
comments, written comments may be
submitted. Any written comments received
will be provided at the meeting and should
be submitted to the contact person below in
advance of the meeting.
For More Information Contact: Theodore
Katz, Executive Secretary, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta GA
30333, Telephone (513) 533–6800, Toll Free
1(800) CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 2, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–16226 Filed 7–8–09; 8:45 am]
rmajette on DSK29S0YB1 with NOTICES
BILLING CODE 4163–18–P
VerDate Nov<24>2008
15:49 Jul 08, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates:
(All times are Eastern Time):
1:30 p.m.–5:45 p.m., July 27, 2009.
9 a.m.–5:30 p.m., July 28, 2009.
9 a.m.–3 p.m., July 29, 2009.
Public Comment Times And Dates: (All
times are Eastern Time):
7 p.m.–8 p.m., July 27, 2009.
5:45 p.m.–6:30 p.m., July 28, 2009.
Place: Cincinnati Marriott North at Union
Centre, 6189 Muhlhauser Road, West
Chester, Ohio; Phone: (800) 228–9290; Fax:
(513) 645–4619. The USA toll free dial in
number is 1–866–659–0537 with a pass code
of 9933701.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 100 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC). In December 2000, the
President delegated responsibility for
funding, staffing, and operating the Advisory
Board to HHS, which subsequently delegated
this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was
issued on August 3, 2001, renewed at
appropriate intervals, and will expire on
August 3, 2009.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the Advisory Board meeting includes: Ethics
training for Board members; NIOSH Program
Status Update; Department of Labor (DOL)
Update; Department of Energy (DOE) Update;
Mound Working Group Update; Special
Exposure Cohort (SEC) Petitions for: Oak
Ridge Hospital, Baker-Perkins Company,
Lake Ontario Ordinance Works, Bliss and
Laughlin Steel, Norton Company, Blockson
Chemical Company (regarding radon-related
dose reconstruction), Dow Chemical
Company (Madison, Illinois), and Chapman
Valve Manufacturing Company; OCAS
Science Update; Dose Reconstruction
Program Report; Special Exposure Cohort
(SEC) Petition Status Updates; Work Group
reports; Reports of the Subcommittees on
Dose Reconstruction Reviews and Procedures
Reviews; and Board Working Time.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted
according to the policy provided below. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public website. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public comment;
(c) A statement such as outlined in (a) above
will also appear with the agenda for a Board
Meeting when it is posted on the NIOSH
website; (d) A statement such as in (a) above
will appear in the Federal Register Notice
that announces Board and Subcommittee
meetings. (3) If an individual in making a
statement reveals personal information (e.g.,
medical information) about themselves that
information will not usually be redacted. The
NIOSH FOIA coordinator will, however,
review such revelations in accordance with
the Freedom of Information Act and the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
E:\FR\FM\09JYN1.SGM
09JYN1
Federal Register / Vol. 74, No. 130 / Thursday, July 9, 2009 / Notices
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Theodore Katz, M.P.A., Executive Secretary,
NIOSH, CDC, 1600 Clifton Road, MS E–20,
Atlanta GA 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 2, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–16223 Filed 7–8–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, August
6, 2009, 1 p.m. to August 6, 2009, 4
p.m., Sheraton Delfina Hotel, 530 West
Pico Boulevard, Santa Monica, CA,
90405 which was published in the
Federal Register on June 8, 2009, 74 FR
27156–27160.
The meeting has been changed to a
telephone conference at the National
Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892. The
meeting date and time remain the same.
The meeting is closed to the public.
Dated: June 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16116 Filed 7–8–09; 8:45 am]
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel P–30 Faculty Recruitment 1.
Date: July 23, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 501 Geary St., San
Francisco, CA 94102.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard;
MSC 9529, Neuroscience Center; Room 3203,
Bethesda, MD 20892–9529, (301) 496–5388,
wiethorp@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel P–30 Faculty Recruitment 2.
Date: July 28, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard;
MSC 9529, Neuroscience Center; Room 3203,
Bethesda, MD 20892–9529, (301) 496–5388,
wiethorp@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences; 93.701, ARRA Related
Biomedical Research and Research Support
Awards, National Institutes of Health, HHS)
Dated: June 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16107 Filed 7–8–09; 8:45 am]
32945
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel. Health and
Retirement Across Nations.
Date: July 28, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20814.
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814.
301–402–7703. ferrellrj@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Effect of
Energy Flux on Risk Factors for Age-Related
Chronic Diseases.
Date: July 30, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications. National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20814 (Telephone
Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Chief, Scientific Review Branch, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C–
212, Bethesda, MD 20892. 301–402–7700.
rv23r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: June 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16105 Filed 7–8–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
rmajette on DSK29S0YB1 with NOTICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Nov<24>2008
15:49 Jul 08, 2009
Jkt 217001
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
August 5, 2009, 8 a.m. to August 6,
2009, 5 p.m., Marriott Bethesda North
Hotel and Conf. Ctr., Bethesda, MD
which was published in the Federal
Register on June 26, 2009, 74FR30592.
E:\FR\FM\09JYN1.SGM
09JYN1
]]>Agencies
[Federal Register Volume 74, Number 130 (Thursday, July 9, 2009)]
[Notices]
[Pages 32944-32945]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16223]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates: (All times are Eastern
Time):
1:30 p.m.-5:45 p.m., July 27, 2009.
9 a.m.-5:30 p.m., July 28, 2009.
9 a.m.-3 p.m., July 29, 2009.
Public Comment Times And Dates: (All times are Eastern Time):
7 p.m.-8 p.m., July 27, 2009.
5:45 p.m.-6:30 p.m., July 28, 2009.
Place: Cincinnati Marriott North at Union Centre, 6189
Muhlhauser Road, West Chester, Ohio; Phone: (800) 228-9290; Fax:
(513) 645-4619. The USA toll free dial in number is 1-866-659-0537
with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC). In December 2000,
the President delegated responsibility for funding, staffing, and
operating the Advisory Board to HHS, which subsequently delegated
this authority to the CDC. NIOSH implements this responsibility for
CDC. The charter was issued on August 3, 2001, renewed at
appropriate intervals, and will expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters To Be Discussed: The agenda for the Advisory Board
meeting includes: Ethics training for Board members; NIOSH Program
Status Update; Department of Labor (DOL) Update; Department of
Energy (DOE) Update; Mound Working Group Update; Special Exposure
Cohort (SEC) Petitions for: Oak Ridge Hospital, Baker-Perkins
Company, Lake Ontario Ordinance Works, Bliss and Laughlin Steel,
Norton Company, Blockson Chemical Company (regarding radon-related
dose reconstruction), Dow Chemical Company (Madison, Illinois), and
Chapman Valve Manufacturing Company; OCAS Science Update; Dose
Reconstruction Program Report; Special Exposure Cohort (SEC)
Petition Status Updates; Work Group reports; Reports of the
Subcommittees on Dose Reconstruction Reviews and Procedures Reviews;
and Board Working Time.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted according to the policy provided below. Any written
comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the
meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment), (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public website. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comment; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH website; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
[[Page 32945]]
information with the Board but objects to doing so in a public
forum, the DFO will work with that individual, in accordance with
the Federal Advisory Committee Act, to find a way that the Board can
hear such comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta
GA 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, E-
mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 2, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-16223 Filed 7-8-09; 8:45 am]
BILLING CODE 4163-18-P
